Law ❯ Securities Law ❯ Regulatory Compliance

FDA Regulations

Drug Approval Process Humanitarian Device Exemption Medical Devices Manufacturing Practices

Savara Investors Pressed to Meet Class-Action Deadlines Over Alleged MOLBREEVI BLA Deficiencies

Lead-plaintiff motions are due this week in suits alleging Savara’s filing lacked required chemistry, manufacturing and controls information.

Cytokinetics Investors Face Nov. 17 Deadline to Seek Lead Role in Aficamten Securities Case

Cytokinetics Investors Urged to Seek Counsel Before Nov. 17 Lead-Plaintiff Deadline in Aficamten Case